ACM
DPLO

AlphaCrest Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

AlphaCrest Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11,100
Closed -$64K – 1185
2019
Q1 		$64K Buy
+11,100
New +$115K 0.01% 796

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AlphaCrest Capital Management's DPLO Position: Q2 2019 in Review

AlphaCrest Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2019, closing a stake of 11,100 shares — an estimated $64K sold.

AlphaCrest Capital Management first reported a position in DPLO in Q1 2019 and held it in 1 quarter. The position peaked at $64K in Q1 2019. 131 funds tracked by Wall St. Rank hold DPLO as of Q2 2019.

  • AlphaCrest Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2019 after selling out during the quarter.
  • AlphaCrest Capital Management sold 11,100 DIPLOMAT PHARMACY, INC. shares in Q2 2019, an estimated $64K.
  • AlphaCrest Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2019 and held it in 1 quarter.
  • AlphaCrest Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $64K in Q1 2019.
  • 131 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2019.

Based on AlphaCrest Capital Management's 13F filing for Q2 2019, filed 12 Aug 2019.